New strategic investment framework for AIDS

Jun 4 2011NewsGuard 100/100 Score

Bernhard Schwartlander and colleagues, on behalf of the Investment Framework Study Group, "propose a strategic investment framework that is intended to support better management of national and international HIV/AIDS responses than exists with the present system" in this Lancet article. According to the authors, the new framework "would avert 12.2 million new HIV infections and 7.4 million deaths from AIDS between 2011 and 2020 compared with continuation of present approaches, and result in 29.4 million life-years gained" (6/3).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Disease/Infection News

Tags: , , , , ,

Comments (0)

Suggested Reading

Dietitians boost GLP-1 therapy success with personalized care and side effect management
Low-dose aspirin does not affect the progression of age-related hearing loss
Predicting behavior from image features: Insights from cortical tuning
Sweden exceeds UNAIDS HIV goals but faces new challenges
Semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic
Study uncovers key mechanism behind HIV latency
Study uncovers mechanism of MX protein in fighting HIV-1 and herpes simplex virus
Innovative HIV vaccine approaches yield potential for broad protection against viral strains

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Semaglutide improves heart health and reduces weight in obese patients, but with side effects